OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

Clinical trial NCT02089113 · COMPLETED

Trial details

NCT number: NCT02089113
Sponsor: Ocular Therapeutix, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Surgical Ocular Pain Post-Surgical Ocular Inflammation

Start date: 2014-04-01
Primary completion: 2015-01-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.